Search details
1.
Plain language summary of the updated results from the CROWN study comparing lorlatinib with crizotinib in people with advanced non-small-cell lung cancer.
Future Oncol
; 19(14): 961-973, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37306090
2.
Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin.
Genome Res
; 29(3): 418-427, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30808726
3.
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma.
Invest New Drugs
; 39(5): 1375-1382, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33856599
4.
The patient's perspective on treatment with dacomitinib: patient-reported outcomes from the Phase III trial ARCHER 1050.
Future Oncol
; 17(7): 783-794, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33164569
5.
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Lancet
; 393(10183): 1819-1830, 2019 05 04.
Article
in English
| MEDLINE | ID: mdl-30955977
6.
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
N Engl J Med
; 376(7): 629-640, 2017 02 16.
Article
in English
| MEDLINE | ID: mdl-27959700
7.
Management of common adverse events related to first-line dacomitinib use in EGFR mutation-positive non-small-cell lung cancer: a pooled safety analysis.
Future Oncol
; 15(13): 1481-1491, 2019 May.
Article
in English
| MEDLINE | ID: mdl-30839234
8.
Effects of dose modifications on the safety and efficacy of dacomitinib for EGFR mutation-positive non-small-cell lung cancer.
Future Oncol
; 15(24): 2795-2805, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31313942
9.
Assessment of programmed cell death ligand-1 expression by 4 diagnostic assays and its clinicopathological correlation in a large cohort of surgical resected non-small cell lung carcinoma.
Mod Pathol
; 31(9): 1381-1390, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29713040
10.
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.
Proc Natl Acad Sci U S A
; 112(11): E1317-25, 2015 Mar 17.
Article
in English
| MEDLINE | ID: mdl-25646427
11.
De-novo and acquired resistance to immune checkpoint targeting.
Lancet Oncol
; 18(12): e731-e741, 2017 12.
Article
in English
| MEDLINE | ID: mdl-29208439
12.
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 18(11): 1454-1466, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28958502
13.
A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma.
Cancer
; 123(20): 3977-3985, 2017 Oct 15.
Article
in English
| MEDLINE | ID: mdl-28640364
14.
Withdrawal of dacomitinib treatment due to absence of toxicities is not justified.
Future Oncol
; 2022 Oct 17.
Article
in English
| MEDLINE | ID: mdl-36250507
15.
Single-Port Video-Assisted Thoracoscopic Major Lung Resections: Experience with 150 Consecutive Cases.
Thorac Cardiovasc Surg
; 64(4): 348-53, 2016 Jun.
Article
in English
| MEDLINE | ID: mdl-25602850
16.
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial.
Lancet Oncol
; 16(8): 990-8, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26159065
17.
Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer.
Cancer
; 121 Suppl 17: 3130-45, 2015 Sep 01.
Article
in English
| MEDLINE | ID: mdl-26331820
18.
Quantifying the benefit of non-small-cell lung cancer immunotherapy - Authors' reply.
Lancet
; 394(10212): 1904-1905, 2019 11 23.
Article
in English
| MEDLINE | ID: mdl-31777386
19.
Osimertinib in EGFR T790M-Positive Lung Cancer.
N Engl J Med
; 376(20): 1993-4, 2017 05 18.
Article
in English
| MEDLINE | ID: mdl-28514610
20.
Crizotinib in the management of advanced-stage non-small-cell lung cancer.
Future Oncol
; 11(5): 735-45, 2015.
Article
in English
| MEDLINE | ID: mdl-25757678